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Abstract
Branched-chain amino acids (BCAA) supplementation has been considered an interesting nutritional strategy to
improve skeletal muscle protein turnover in several conditions. In this context, there is evidence that resistance
exercise (RE)-derived biochemical markers of muscle soreness (creatine kinase (CK), aldolase, myoglobin), soreness,
and functional strength may be modulated by BCAA supplementation in order to favor of muscle adaptation.
However, few studies have investigated such effects in well-controlled conditions in humans. Therefore, the aim of
this short report is to describe the potential therapeutic effects of BCAA supplementation on RE-based muscle
damage in humans. The main point is that BCAA supplementation may decrease some biochemical markers
related with muscle soreness but this does not necessarily reflect on muscle functionality.
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Introduction
Skeletal muscle damage is a phenomenon that can occur
due to several factors, such as rupture and/or cell necro-
sis, representing about 10-55% of total muscular injuries
[1]. The main feature of skeletal muscle damage without
cell necrosis is the disruption of muscle fibers, specifi-
cally the sheath of basal lamina [1]. Regarding mechani-
cal stimuli, specifically resistance exercise (RE), it is
known that it can promote microdamage in muscle
fibers imposed by contractions and/or overload and,
according to the intensity, length, and volume the sever-
ity and degree of damage and discomfort may be com-
pounded over time and persist chronically [2]. As
functional consequence, muscle damage is manifested
by a temporary decrease in strength, increased muscle
passive tension, delayed onset muscle soreness (DOMS),
and edema [2].
In this context, some prophylactic interventions have
been proposed in order to attenuate the negative effects
associated with RE-induced muscle damage. Among the
nutritional strategies, supplementation with branched-
chain amino acids (BCAA - leucine, isoleucine, and
valine) has been considered a potential intervention
[3,4]. It is known that these amino acids, particularly
leucine, have anabolic potential by stimulating the initia-
tion of protein translation [5], possibly suppressing/
attenuating muscle proteolysis [6], and offering its trans-
amination product alpha-ketoisocaproate (a-KIC),
widely known to inhibit the enzymatic activity of the
branched-chain alpha-keto dehydrogenase complex
(BCKDH) which increases BCAA oxidation [7,8]. Thus,
BCAA supplementation could promote interesting
effects on muscle repair by reducing protein oxidation,
promoting muscle sarcomerogenesis, and improving
muscle functional status.
The purpose of this short review is to describe the
effects of BCAA supplementation on RE-induced muscle
damage. To this, we considered only human studies
since they can elucidate a possible nutritional strategy
with therapeutic potential. This strategy may promote
benefits such as attenuate muscle soreness and improve
skeletal muscle turnover to subjects engaged on resis-
tance exercise program which could favor RE-induced
training adaptations. To this end, this report discusses
the basic concepts of muscle damage and its biochem-
ical markers followed by evidences of effects of BCAA
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supplementation on RE-induced muscle damage in
humans.
Discussion
Cellular responses and biochemical markers of muscle
damage
The damage of muscle tissue can be defined as the dis-
ruption of plasma membrane accompanied by the loss
of muscle proteins (i.e. creatine kinase (CK), myoglobin,
lactate dehydrogenase (LDH), aldolase, troponin), the
influx of serum proteins, increased population of inflam-
matory infiltrates in the muscle fibers (i.e. macrophages
and neutrophils), DOMS, functional impairment
(strength loss), and possible structural disorders such as
sarcomere Z lines disarrangement [9,10]. Current litera-
ture classifies the damage of skeletal muscle in two
stages called primary and secondary damage [2]. The
primary damage can be subdivided into two possible
mechanisms: metabolic and mechanical. The metabolic
damage has been proposed as a result of ischemia or
hypoxia during prolonged exercise, which may results in
changes in ion concentration, accumulation of metabolic
wastes, and deficiency of adenosine triphosphate (ATP)
[11]. Mechanical stimuli, however, may induce muscle
damage as direct consequence of overload of muscle
fibers or inappropriate balance of exercise variables that
can cause the disruption of the sarcomeric Z lines [2],
[9,10]. The secondary damage can be manifested
through processes associated with exercise that can lead
to disruption of intracellular calcium homeostasis and
systemic and local inflammatory response [11]. Of note,
it has been proposed that RE-induced muscle damage
may be a necessary step to favor muscle remodeling and
adaptation [12]. However, chronic muscle damage may
delay muscle recovery, functionality, and impair protein
turnover [13,14].
Enzymatic skeletal muscle proteins such as CK, LDH,
myoglobin, and myosin heavy chain (MHC) may spill
from muscle cells to the serum and be used as quantita-
tive markers of cellular damage and recovery [15]. RE
may affect the structure of skeletal muscle cells at the
sarcolemma and Z disks resulting in increased serum
levels of CK. Of note, the time-release and clearance of
CK depends mainly on the type of exercise and its vari-
ables (volume, intensity, and duration). Apparently, this
relationship is mainly dependent of intensity and volume
[16]. When exercise intensity is mild/moderate and with
low volume, muscle tissue does not undergo significant
changes in membrane permeability [17,18]. However,
with high intensity and low/moderate volume or low/
moderate intensity and with high volume, changes in
membrane permeability and increase in serum CK and
the enzymes mentioned above may occur. Importantly,
serum CK concentration has been associated with
muscle functional properties such as strength impair-
ment and reduced ATP resynthesis [9,19,20]. LDH is
also a widely used marker of cellular damage. It is
already known that mechanical stimuli can induce sig-
nificant increase of serum LDH and the degree of
increase depends on the intensity and duration of the
exercise [19,21,22]. This relationship has been demon-
strated in several studies [23-25]. Myoglobin is another
consistently used biochemical marker of muscle damage.
After strenuous exercise, myoglobin is released as a
result of degradation of muscle protein structures
[19,26,27]. Its serum concentration may be elevated for
some days probably due to the low-grade inflammation.
The activity of myoglobin has strong correlation with
the response of neutrophils induced by stress and is
therefore a useful marker for monitoring the integrity of
skeletal muscle tissue [19,26,27]. Among the markers
mentioned above, most studies observed high inter-sub-
ject variability in the activity of CK and LDH in
response to RE-induced muscle damage [21,22,28]. In
contrast, myoglobin appears to be more applicable since
their variability is reduced when compared to the others
[27].
BCAA supplementation and RE-induced muscle damage:
results of human studies
Recent studies suggest that BCAA supplementation may
improve the repair of RE-induced damaged muscle tis-
sue. Shimomura et al. [29] assessed serum free amino
acids concentration in young untrained women supple-
mented with BCAA (5.5 g BCAA in 1.0 g of green tea)
15 minutes prior to performing a squat exercise (7 sets
of 20 repetitions). The authors observed that serum
BCAA concentrations were significantly decreased in
the placebo group when compared to the supplemented
group (2.2-fold higher), suggesting that the exercise pro-
tocol induced significant BCAA oxidation and the sup-
plementation prevented such effect. Furthermore,
another study from the same group [30] found that
BCAA supplementation (5 g) 15 minutes before the
same RE protocol reduced the peak time of muscle sore-
ness (2-3 days after exercise) in young women by about
45% when compared to the placebo group (dextrin) and
this reduction was significant up to 5 days after exercise.
These data demonstrate that RE-induced muscle
damage increase BCAA uptake from serum to skeletal
muscle in order to be used as energy source and/or par-
ticipate in translation initiation signaling pathway
involved in muscle remodeling. Functionally, this
appears to have some consequence in muscle pain.
Concerning the time-frame of supplementation,
Nosaka et al. [3] evaluated the effects on muscle damage
supplementing an amino acid mixture (BCAA-enriched;
60% of essential amino acids) 30 minutes before,
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immediately after, and 4 days post-exercise (900 actions
of arm curl with 1.80 to 3.44 kg of range of workload).
No significant differences were observed in the supple-
mented group 30 minutes before and immediately after
exercise regarding muscle soreness and damage indexes.
However, subjects who ingested the amino acid mixture
during 4 days post-exercise presented reduction of
serum CK (from 48 to 96 hours), myoglobin (from 24 to
96 hours), and of muscle soreness (from 24 to 96 hours)
when compared with the placebo group. However,
although no significant differences were observed
between groups in isometric maximal voluntary contrac-
tion, range of motion, upper arm circumference, and
muscle discomfort were decreased up to 4 days after
exercise in the supplemented group. These results
demonstrate that BCAA supplementation may attenuate
muscle soreness and this can be related with some bio-
chemical markers. However, since no results were
observed in muscle strength we can postulate that the
benefits of BCAA supplementation do not involve struc-
tural modulation. Similar responses were observed in
the study conducted by Sharp & Pearson [31] which
supplemented male subjects with BCAA (1.8 g of leu-
cine, 0.75 g of isoleucine, and 0.75 g of valine) during 3
weeks before and 1 week during a high-intensity total-
body RE (3 sets of 8 repetitions maximum, 8 exercises)
and observed that serum CK was significantly reduced
in BCAA supplemented group during and following the
exercise protocol.
In a very elegant study, Jackman et al. [32] evaluated
the effects of BCAA supplementation (3.5 g of leucine,
2.1 g of isoleucine, and 1.7 g of valine; divided in 4 daily
doses) on eccentric exercise-induced muscle damage.
The main feature of this study was that the subjects
remained in dietary control throughout the experimental
protocol in order to minimize the possible effects of
other nutrients on the cellular and functional responses.
In the exercise day (12 sets of 10 repetitions at 120% of
concentric 1 repetition maximum), subjects consumed
the supplement 30 minutes before, 1.5 hour after,
between lunch and dinner, and before bed; on the fol-
lowing 2 days, 4 doses of supplementation given
between meals. Serum CK and myoglobin were signifi-
cantly increased after exercise and remained throughout
the test period and BCAA supplementation did not atte-
nuated it. However, muscle soreness increased after
exercise and was 64% reduced in BCAA supplemented
group when compared to the placebo group. Thus, it
appears that BCAA supplementation can also modulate
muscle soreness independently of biochemical markers.
Such information need to be elucidated by future stu-
dies. In practice, these results reinforce the hypothesis
that, although BCAA supplementation does not improve
muscle function, it can alleviate RE-induced muscle
soreness and favor the subject to perform another RE
session (the phenomenon called “repeated bout effect”).
Table 1 summarizes the main results described in the
text.
Conclusions and perspectives
According to the data presented, BCAA supplementation
appears to be an interesting nutritional intervention to
alleviate RE-induced muscle soreness. Although some
studies have found that biochemical markers of muscle
damage are reduced after BCAA supplementation, it
does not reflect improved muscle function (at least in
short term studies). Paradoxically, although RE, especially
lengthening (eccentric) contractions, is associated with
muscle injury, they can also provide significant protec-
tion against future muscle damage and are robustly
involved in the hypertrophy process [33]. However, little
is known about the conditions that result in the protec-
tive adaptation involving the repeated bout effect and the
role of BCAA supplementation in this context. Thus,
future studies should try chronic BCAA supplementation
(and even other amino acids) against placebo with the
Table 1 Studies investigating the effects of BCAA supplementation of RE-based muscle damage in humans
Study Exercise Protocol Supplementation Protocol Results
Shimomura
et al. [29]
Squat (7 sets of 20 repetitions) 5.5 g of BCAA within 1.0 g of green tea 15 min
before exercise
Attenuation of exercise-induced serum
BCAA oxidation.
Shimomura
et al. [30]
Squat (7 sets of 20 repetitions) 5.0 g of BCAA 15 min before exercise Reduction of peak time of muscle
soreness induced by exercise.
Nosaka et
al.[3]
900 actions (30 min) of arm curl
with 1.80 to 3.44 kg of range of
workload
BCAA-enriched amino acid mixture (60% of the
essential amino acids)
Reduction of serum CK, myoglobin, and
muscle soreness. No differences in
isometric MVC.
Sharp &
Pearson
[31]
Whole body RE (3 sets of 8 RM, 8
exercises)
BCAA (1.8 g of leucine, 0.75 g of isoleucine, and 0.75
g of valine) 3 weeks before and 1 week during
exercise protocol
Reduction of serum CK.
Jackman et
al. [32]
Eccentric exercise (12 sets of 10
repetitions at 120% of concentric
1RM)
~ 7.0 g of BCAA/day (divided in 4 doses) on the
following 2 days after exercise
No differences in serum CK and
myoglobin; Attenuation in exercise-
induced muscle soreness.
BCAA = branched-chain amino acids; CK = creatine kinase; MVC = maximal voluntary contraction; RE = resistance exercise; RM = repetition maximum.
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same nitrogen load (isonitrogenous supplementation pro-
tocol) in order to evaluate the possible impact on muscle
functionality and relate such effects with molecular path-
ways involved in muscle repair and regeneration.
List of abbreviations
α- KIC: alpha-ketoisocaproate; ATP: adenosine triphosphate; BCAA: branched-
chain amino acids; BCKDH: branched-chain alpha-keto dehydrogenase
complex; CK: creatine kinase; DOMS: delayed onset muscle soreness; LDH:
lactate dehydrogenase; MHC: myosin heavy chain; RE: resistance exercise.
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